Department of Neurological Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Department of Surgery, Zuoying Branch, Kaohsiung Arm Force General Hospital, Kaohsiung, Taiwan.
PLoS One. 2018 Nov 19;13(11):e0207612. doi: 10.1371/journal.pone.0207612. eCollection 2018.
Although proton magnetic resonance spectroscopy (1H-MRS) is a common method for the evaluation of intracranial meningiomas, controversy exists regarding which parameter of 1H-MRS best predicts the histopathological grade of an intracranial meningioma. In this study, we evaluated the results of pre-operative 1H-MRS to identify predictive factors for high-grade intracranial meningioma. Thirteen patients with World Health Organization (WHO) grade II-III meningioma (confirmed by pathology) were defined as high-grade; twenty-two patients with WHO grade I meningioma were defined as low-grade. All patients were evaluated by 1H-MRS before surgery. The relationships between the ratios of metabolites (N-acetylaspartate [NAA], creatine [Cr], and choline [Cho]) and the diagnosis of high-grade meningioma were analyzed. According to Mann-Whitney U test analysis, the Cho/NAA ratio in cases of high-grade meningioma was significantly higher than in cases of low-grade meningioma (6.34 ± 7.90 vs. 1.58 ± 0.77, p<0.05); however, there were no differences in age, Cho/Cr, or NAA/Cr. According to conditional inference tree analysis, the optimal cut-off point for the Cho/NAA ration between high-grade and low-grade meningioma was 2.409 (sensitivity = 61.54%; specificity = 86.36%). This analysis of pre-operative 1H-MRS metabolite ratio demonstrated that the Cho/NAA ratio may provide a simple and practical predictive value for high-grade intracranial meningiomas, and may aid neurosurgeons in efforts to design an appropriate surgical plan and treatment strategy before surgery.
尽管质子磁共振波谱(1H-MRS)是评估颅内脑膜瘤的常用方法,但对于哪种 1H-MRS 参数最能预测颅内脑膜瘤的组织病理学分级仍存在争议。在本研究中,我们评估了术前 1H-MRS 的结果,以确定预测高级别颅内脑膜瘤的因素。将 13 例经病理证实为世界卫生组织(WHO)分级 II-III 级的脑膜瘤(WHO 分级 II-III 级)患者定义为高级别;22 例 WHO 分级 I 级脑膜瘤患者定义为低级别。所有患者均在术前进行 1H-MRS 评估。分析代谢物(N-乙酰天冬氨酸[NAA]、肌酸[Cr]和胆碱[Cho])比值与高级别脑膜瘤诊断之间的关系。根据 Mann-Whitney U 检验分析,高级别脑膜瘤病例的 Cho/NAA 比值明显高于低级别脑膜瘤病例(6.34±7.90 比 1.58±0.77,p<0.05);然而,年龄、Cho/Cr 或 NAA/Cr 无差异。根据条件推断树分析,高级别和低级别脑膜瘤之间 Cho/NAA 比值的最佳截断点为 2.409(灵敏度=61.54%;特异性=86.36%)。术前 1H-MRS 代谢物比值分析表明,Cho/NAA 比值可能为高级别颅内脑膜瘤提供一种简单实用的预测价值,并可能有助于神经外科医生在术前制定适当的手术计划和治疗策略。
Jpn J Cancer Res. 1995-3
J Neurol Sci. 2009-9-15
Clin Radiol. 2015-1
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017-8-20
J Comput Assist Tomogr. 1990
Adv Biomed Res. 2025-7-31
Comput Intell Neurosci. 2022
Neurol Neurochir Pol. 2013
Clin Neurol Neurosurg. 2013-2
J Neurooncol. 2012-2-12
Magn Reson Imaging. 2010-9-15
Neurosurg Focus. 2007
AJNR Am J Neuroradiol. 2006-8